Healthcare networks are integrating targeted rapid genomic sequencing into routine diagnostic workflows to shorten the window between screening and treatment.
Time-to-Treatment Reduction
Pilot programs demonstrate that in-house sequencing cuts turnaround times for actionable genetic markers from two weeks to under 48 hours.
Reimbursement Integration
Insurance providers are adjusting coverage policies to reflect the long-term cost savings associated with precise early-stage pharmaceutical interventions.